Evaric Pharmaceuticals Inc
Form 483 issued May 29, 2019 · HAUPPAUGE, New York
- Observations
- 1
- Pages
- 2
- FEI number
- 3013061208
In short: On May 29, 2019, FDA issued a Form 483 with 1 observation to Evaric Pharmaceuticals Inc in HAUPPAUGE, New York (FEI 3013061208). Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.63 (equipment design, size, and location).
At a glance
1 of 1 observations on this 483 concern facilities & equipment.
Most cited: 21 CFR 211.63 (1×)
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
You are not ready for the…
This inspection in context
Questions about this 483
What did FDA find at Evaric Pharmaceuticals Inc?
FDA listed 1 observation on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.63 (equipment design, size, and location). The opening words of each observation are shown on this page.
When was Evaric Pharmaceuticals Inc inspected by FDA?
This Form 483 is dated May 29, 2019.
How do I get the full Form 483 for Evaric Pharmaceuticals Inc?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.